2 behavioral health providers to affiliate under Boundless name
Impact on your practice
This is a provider consolidation news item with limited direct impact on independent therapists or smaller practices. It signals industry consolidation trends but does not affect reimbursement, licensing, or regulatory requirements.
Key facts
Boundless (Ohio) and Merakey USA (Pennsylvania) have affiliated under shared governance
Combined organization serves 50,000+ individuals across 12 states with 11,000+ employees and $1B+ annual revenue
Affiliation focuses on workforce development, technology, data analytics, and operational excellence
States affected
Policy changes drive denial patterns
Therapy Companion tracks both: the policy shifts on this page and the denial patterns hitting your claims.
Related policy changes
A New Federal Interpretation Challenges the ‘Gold Standard’ of SMI Care
This DOJ memo could fundamentally reshape where and how community-based mental health services are funded and delivered. Therapists working in community-integrated programs or value-based models should monitor this closely, as it may affect referral patterns, funding models, and scope of practice in community settings.
Behavioral Health Billing Fraud, Kickbacks Totalled $208M in Massive DOJ Fraud Bust
This enforcement action underscores heightened scrutiny of behavioral health billing practices, particularly around rapidly-growing modalities like TMS. Therapists and practices should audit billing accuracy and documentation, especially in high-fraud areas. Overly aggressive billing practices or inadequate supervision documentation now carry real federal prosecution risk.
Advancing the Future of Behavioral Health Data Exchange
Better behavioral health data exchange is a regulatory and operational priority that will likely drive new EHR interoperability requirements and documentation standards for therapists. Understanding this movement helps practices anticipate compliance changes.
STAT+: Trump’s boosting of psychedelics, cannabis signal a new era in GOP drug policy
Federal marijuana rescheduling will complicate assessment, treatment planning, and documentation for therapists, particularly around substance use evaluation and dual diagnoses. Therapists in legal marijuana states will need updated clinical guidelines and liability coverage clarity.